Monte Rosa Therapeutics
GLUE
GLUE
66 hedge funds and large institutions have $314M invested in Monte Rosa Therapeutics in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less capital invested
Capital invested by funds: $328M → $314M (-$14.1M)
6% less funds holding
Funds holding: 70 → 66 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Holders
66
Holding in Top 10
1
Calls
$489K
Puts
$11K
Top Buyers
| 1 | +$7.32M | |
| 2 | +$2.79M | |
| 3 | +$976K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$253K |
| 5 |
State Street
Boston,
Massachusetts
|
+$250K |
Top Sellers
| 1 | -$761K | |
| 2 | -$748K | |
| 3 | -$700K | |
| 4 |
O
OrbiMed
New York
|
-$686K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$608K |